Insights

Expansion in Stock Repurchase Program Exelixis recently authorized an additional $500 million stock repurchase program, indicating confidence in its financial stability and potential for growth. This move showcases a commitment to maximizing shareholder value and could present an opportunity for strategic partnerships or investment opportunities.

Positive Market Response to Stock Performance Exelixis experienced a 6.7% stock price increase post Q4 earnings announcement, driven by strong performance of its lead drug Cabometyx and promising pipeline developments. This positive market reception signals a potential window for engaging with investors, highlighting the company's growth prospects and innovative products.

Sustained Efficacy Benefits in Cancer Treatment Trials Results from Exelixis' phase 3 CheckMate -9ER trial demonstrated sustained long-term efficacy benefits of its cancer treatment, CABOMETYX, in combination with Opdivo. This could present an opportunity to engage with healthcare providers and institutions looking for advanced renal cell carcinoma treatment options.

Solid Growth Stock Potential Analysis indicates that Exelixis is considered a solid growth stock with the potential to deliver exceptional returns. This recognition could serve as a point of entry to engage with investors seeking promising investment opportunities in the biotechnology sector.

International Revenue Trends and Expansion Exploring Exelixis' international revenue trends offers insights into its global market presence and growth potential. Understanding how international markets impact the company's forecasts can provide sales development representatives with opportunities to tap into new markets and tailor strategies for international expansion.

Exelixis Tech Stack

Exelixis uses 8 technology products and services including Reinvigorate, Hyperion, Google Cloud, and more. Explore Exelixis's tech stack below.

  • Reinvigorate
    Analytics
  • Hyperion
    Corporate Performance Management
  • Google Cloud
    Infrastructure As A Service
  • Microsoft Active Directory
    IT Infrastructure
  • Thomson Reuters Legal Tracker
    Legal Solutions
  • Palo Alto Networks
    Network Security
  • SUSE
    Operating Systems
  • Microsoft Azure
    Platform As A Service

Media & News

Exelixis's Email Address Formats

Exelixis uses at least 1 format(s):
Exelixis Email FormatsExamplePercentage
FLast@exelixis.comJDoe@exelixis.com
82%
First.Last@exelixis.comJohn.Doe@exelixis.com
12%
FiLast@exelixis.comJoDoe@exelixis.com
3%
FirstLast@exelixis.comJohnDoe@exelixis.com
3%

Frequently Asked Questions

Where is Exelixis's headquarters located?

Minus sign iconPlus sign icon
Exelixis's main headquarters is located at 1851 Harbor Bay Pkwy Alameda, California 94502 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Exelixis's phone number?

Minus sign iconPlus sign icon
You can contact Exelixis's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Exelixis's stock symbol?

Minus sign iconPlus sign icon
Exelixis is a publicly traded company; the company's stock symbol is EXEL.

What is Exelixis's official website and social media links?

Minus sign iconPlus sign icon
Exelixis's official website is exelixis.com and has social profiles on LinkedIn.

How much revenue does Exelixis generate?

Minus sign iconPlus sign icon
As of January 2025, Exelixis's annual revenue reached $1.8B.

What is Exelixis's SIC code NAICS code?

Minus sign iconPlus sign icon
Exelixis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exelixis have currently?

Minus sign iconPlus sign icon
As of January 2025, Exelixis has approximately 1.4K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: C. U.Chief Financial Officer: G. P.Chief Business Officer: R. H.. Explore Exelixis's employee directory with LeadIQ.

What industry does Exelixis belong to?

Minus sign iconPlus sign icon
Exelixis operates in the Biotechnology Research industry.

What technology does Exelixis use?

Minus sign iconPlus sign icon
Exelixis's tech stack includes ReinvigorateHyperionGoogle CloudMicrosoft Active DirectoryThomson Reuters Legal TrackerPalo Alto NetworksSUSEMicrosoft Azure.

What is Exelixis's email format?

Minus sign iconPlus sign icon
Exelixis's email format typically follows the pattern of . Find more Exelixis email formats with LeadIQ.

How much funding has Exelixis raised to date?

Minus sign iconPlus sign icon
As of January 2025, Exelixis has raised $135M in funding. The last funding round occurred on Jul 23, 2015 for $135M.

When was Exelixis founded?

Minus sign iconPlus sign icon
Exelixis was founded in 1994.
Exelixis

Exelixis

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.

After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. 

Cancer is our cause. Make it yours, too. 

Please see our Community Guidelines: bit.ly/2XXw9w3

For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

Section iconCompany Overview

Headquarters
1851 Harbor Bay Pkwy Alameda, California 94502 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EXEL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
1001-5000

Section iconFunding & Financials

  • $135M

    Exelixis has raised a total of $135M of funding over 5 rounds. Their latest funding round was raised on Jul 23, 2015 in the amount of $135M.

  • $1B

    Exelixis's revenue is in the range of $1B

Section iconFunding & Financials

  • $135M

    Exelixis has raised a total of $135M of funding over 5 rounds. Their latest funding round was raised on Jul 23, 2015 in the amount of $135M.

  • $1B

    Exelixis's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.